A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer.

[1]  W. Kassouf,et al.  Biomarkers for detection and surveillance of bladder cancer. , 2013, Canadian Urological Association journal = Journal de l'Association des urologues du Canada.

[2]  Duan Ma,et al.  The cell growth suppressor, mir-126, targets IRS-1. , 2008, Biochemical and biophysical research communications.

[3]  Kishore Guda,et al.  The noncoding RNA, miR‐126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3‐kinase signaling and is frequently lost in colon cancers , 2008, Genes, chromosomes & cancer.

[4]  G. Nuovo,et al.  MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. , 2008, Biochemical and biophysical research communications.

[5]  Joshua T. Mendell,et al.  MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1 , 2008, Proceedings of the National Academy of Sciences.

[6]  W. Gerald,et al.  Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.

[7]  D. Jocham,et al.  Detailed technical analysis of urine RNA-based tumor diagnostics reveals ETS2/urokinase plasminogen activator to be a novel marker for bladder cancer. , 2007, Clinical chemistry.

[8]  George A Calin,et al.  Micro-RNA profiling in kidney and bladder cancers. , 2007, Urologic oncology.

[9]  D. Valle,et al.  MicroRNA (miRNA) Transcriptome of Mouse Retina and Identification of a Sensory Organ-specific miRNA Cluster* , 2007, Journal of Biological Chemistry.

[10]  Stefanie Dimmeler,et al.  Role of Dicer and Drosha for Endothelial MicroRNA Expression and Angiogenesis , 2007, Circulation research.

[11]  Michael A. Beer,et al.  Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.

[12]  M. Menon,et al.  Identification of prostate cancer mRNA markers by averaged differential expression and their detection in biopsies, blood, and urine , 2007, Proceedings of the National Academy of Sciences.

[13]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[14]  L. Marks,et al.  APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. , 2006, Clinical chemistry.

[15]  C. Croce,et al.  A microRNA expression signature of human solid tumors defines cancer gene targets , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Rajewsky,et al.  Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.

[17]  K. Miller,et al.  Quantitative evaluation of telomerase subunits in urine as biomarkers for noninvasive detection of bladder cancer , 2005, International journal of cancer.

[18]  H. Horvitz,et al.  MicroRNA expression profiles classify human cancers , 2005, Nature.

[19]  H. Razvi,et al.  A prospective evaluation of the diagnostic and potential prognostic utility of urinary human telomerase reverse transcriptase mRNA in patients with bladder cancer. , 2004, The Canadian journal of urology.

[20]  T. Fujioka,et al.  Detection of the presence of catalytic subunit mRNA associated with telomerase gene in exfoliated urothelial cells from patients with bladder cancer. , 2002, The Journal of urology.

[21]  H. Razvi,et al.  Comparison of Human Telomerase Reverse Transcriptase Messenger RNA and Telomerase Activity as Urine Markers for Diagnosis of Bladder Carcinoma , 2000, Molecular Diagnosis.

[22]  D. Swinkels,et al.  Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas. , 2000, Clinical chemistry.

[23]  D. Swinkels,et al.  Detection of telomerase activity in urine as a tool for noninvasive detection of recurrent bladder tumors is poor and cannot be improved by timing of sampling. , 2000, Clinical chemistry.

[24]  D. Swinkels,et al.  Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas , 2000, International journal of cancer.

[25]  D. Swinkels,et al.  Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues. , 2000, Clinical chemistry.

[26]  S. Kyo,et al.  Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[27]  S. Kyo,et al.  Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  K. Rieger-Christ,et al.  A microRNA expression ratio defining the invasive phenotype in bladder tumors. , 2010, Urologic oncology.